Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 5/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15928015 | 1.00 | LPL (0.42) | LPLLIPGTSHRTHRBDNM1 | |
| SCHEMBL20139091 | 1.00 | LPL (0.42) | LPLLIPGTSHRTHRBDNM1 | |
| SCHEMBL20535700 | 1.00 | LPL (0.42) | LPLLIPGTSHRTHRBDNM1 | |
| SCHEMBL15927978 | 1.00 | LPL (0.42) | LPLLIPGTSHRTHRBDNM1 | |
| SCHEMBL15923410 | 1.00 | LPL (0.42) | LPLLIPGTSHRTHRBDNM1 | |
| SCHEMBL6938183 | 1.00 | LPL (0.42) | LPLLIPGTSHRTHRBDNM1 | |
| SCHEMBL18387576 | 0.90 | LPL (0.37) | LPLLIPGTSHRLMNA | |
| SCHEMBL23969676 | 0.90 | ANPEP (0.31) | LPLLIPG | |
| SCHEMBL20535258 | 0.88 | FAAH (0.44) | LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL20535262 | 0.88 | FAAH (0.44) | LMNAMEN1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043636-B2 | Method for producing triarylorganoborates | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2024-07-23 | — | — | US | disclosed |
| US-20240002409-A1 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | COVESTRO DEUTSCHLAND AG (DE) | 2024-01-04 | — | — | US | disclosed |
| US-11760765-B2 | Method for producing triarylorganoborates | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2023-09-19 | — | — | US | disclosed |
| CN-110325521-B | Process for preparing triarylorganoborates | 科思创德国股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-110177797-B | Method for producing triaryl organic borate salts | 科思创德国股份有限公司 | 2022-09-23 | — | — | CN | disclosed |
| CN-109679045-B | Novel green reinforcing resin for tire rubber and composition thereof | 山东圣泉新材料股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20220002321-A1 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | COVESTRO DEUTSCHLAND AG (DE) | 2022-01-06 | — | — | US | disclosed |
| US-11078218-B2 | Process for the production of triaryl organoborates | COVESTRO DEUTSCHLAND AG (DE) | 2021-08-03 | — | — | US | disclosed |
| EP-3583092-B1 | COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2021-05-26 | — | — | EP | disclosed |
| US-20190276479-A1 | PROCESS FOR THE PRODUCTION OF TRIARYL ORGANOBORATES | COVESTRO DEUTSCHLAND AG (DE) | 2019-09-12 | — | — | US | disclosed |
| US-20190263838-A1 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | COVESTRO DEUTSCHLAND AG (DE) | 2019-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002409-A1 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | KMO, COASY, CYP3A4 | LPL 1072/4885LIPG 592/4885TSHR 3184/4885 |
| US-11078218-B2 | Process for the production of triaryl organoborates | OR10J3, CYP4F3, CYP4B1 | LPL 4604/4885LIPG 4125/4885TSHR 2354/4885 |
| US-12043636-B2 | Method for producing triarylorganoborates | KMO, COASY, CYP3A4 | LPL 1072/4885LIPG 592/4885TSHR 3184/4885 |
| US-20190263838-A1 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | CYP3A4, CYP3A43, CYP4B1 | LPL 652/4885LIPG 452/4885TSHR 3341/4885 |
| US-20220002321-A1 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | CYP3A4, CYP3A43, CYP4B1 | LPL 652/4885LIPG 452/4885TSHR 3341/4885 |
| US-11760765-B2 | Method for producing triarylorganoborates | CYP3A4, CYP3A43, CYP4B1 | LPL 652/4885LIPG 452/4885TSHR 3341/4885 |
| US-20190276479-A1 | PROCESS FOR THE PRODUCTION OF TRIARYL ORGANOBORATES | CYP1B1, CYP3A4, CYP4B1 | LPL 3036/4885LIPG 2339/4885TSHR 3103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.